| Report ID | Date of report | Patient age | Patient gender |
| 162022 | Jul, 11, 2006 | 55 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Mylotarg | gemtuzumab ozogamicin |
| Name |
Acute Myeloid Leukaemia |
Alanine Aminotransferase Increased |
Aspartate Aminotransferase Increased |
Blood Alkaline Phosphatase Increased |
Blood Lactate Dehydrogenase Increased |
Malignant Neoplasm Progression |
Weight Increased |
Results from eHealthMe : 3164 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Acute Myeloid Leukaemia | 193 (6.10%) |
Alanine Aminotransferase Increased | 304 (9.61%) |
Aspartate Aminotransferase Increased | 418 (13.21%) |
Blood Alkaline Phosphatase Increased | 266 (8.41%) |
Blood Lactate Dehydrogenase Increased | 211 (6.67%) |
Malignant Neoplasm Progression | 154 (4.87%) |
Weight Increased | 294 (9.29%) |
Top 3 (total: 1075. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Cytarabine | 619 (3.65%) |
Acyclovir | 411 (2.42%) |
Allopurinol | 401 (2.36%) |
Death reported: 23 (0.73% of total reports)
| Name | Count (% of total reports) |
Febrile Neutropenia | 718 (22.69%) |
Pyrexia | 587 (18.55%) |
Platelet Count Decreased | 506 (15.99%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
